|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 216.15 USD | +0.99% |
|
-2.59% | -5.40% |
| 01-20 | Global drugmakers rush to boost US presence as tariff threat looms | RE |
| 01-20 | Berenberg Lifts Price Target on AbbVie to $275 From $270, Keeps Buy Rating | MT |
Sales 2024 by Business Segment
Sales 2024 by Geography
Historical Breakdown of Revenue by Business Segments
Net Income: Breakdown by Business Segment
| Fiscal Period: December | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|---|---|---|
Biological Products | ||||||||||
Innovative Medicines and Therapies | 45.8B | 56.2B | 58.05B | 54.32B | 56.33B | |||||
Total Assets | 151B | 147B | 139B | 135B | 135B | |||||
Interest Expense | -2.45B | -2.42B | -2.23B | -2.22B | -2.81B | |||||
Income Tax Expense | -1.22B | 1.44B | 1.63B | 1.38B | -570M | |||||
CAPEX | -798M | -787M | -695M | -777M | -974M | |||||
EBT | 3.4B | 12.99B | 13.48B | 6.25B | 3.72B | |||||
D&A | 6.47B | 8.52B | 8.47B | 8.7B | 8.39B | |||||
Operating Income | 11.36B | 17.92B | 18.12B | 12.76B | 9.14B | |||||
Net Income | 4.62B | 11.54B | 11.84B | 4.86B | 4.28B |
Geographical Revenue Distribution History
| Fiscal Period: December | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|---|---|---|
United States | 34.88B | 43.51B | 45.71B | 41.88B | 43.03B | |||||
ALL Other Countries | 3.98B | 4.76B | 4.84B | 5.04B | 5.45B | |||||
Total Assets | 360M | 341M | 323M | 417M | 318M | |||||
Total Assets | 3.35B | 3.37B | 3.24B | 3.14B | 3.33B | |||||
Total Assets | 1.53B | 1.4B | 1.37B | 1.43B | 1.48B | |||||
Germany | 1.05B | 1.22B | 1.34B | 1.27B | 1.46B | |||||
Japan | 1.2B | 1.09B | 956M | 1.01B | 1.12B | |||||
Canada | 1.16B | 1.4B | 1.16B | 1.08B | 1.09B | |||||
China | 471M | 857M | 912M | 950M | 917M | |||||
France | 797M | 936M | 787M | 780M | 776M | |||||
Spain | 453M | 519M | 506M | 501M | 528M | |||||
United Kingdom | 509M | 497M | 462M | 417M | 522M | |||||
Italy | 379M | 506M | 444M | 484M | 511M | |||||
Brazil | 406M | 368M | 430M | 439M | 464M | |||||
Australia | 527M | 533M | 508M | 472M | 463M | |||||
The Netherlands | - | - | - | - | - |
- Stock Market
- Equities
- ABBV Stock
- Financials AbbVie Inc.
- Business Segments
Select your edition
All financial news and data tailored to specific country editions
MarketScreener is also available in this country: United States.
Switch edition